1. Teoh-Chan CH, Cowlishaw A, Eley A, Slater G, Greenwood D (1985) Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid. JAntimicrob Chemother 15: 45–52
2. Ohshita Y, Hayashi N, Amano H, Hirao Y, Niino Y, Yazaki A, Kobayashi Y (1998) WQ-3034, A novel acidic fluoroquinolone: in vitro and in vivo antimicrobial activities. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego. Poster F-084
3. Huczko E, Valera L, Conetta B, Stickle T, Macko A, Fung-Tomc J (1999) Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from the clinical trails during the 1997–1998 Period. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco. Poster F-0351
4. Fass RJ (1997) In vitro activity of Bay 12–8038, a new 8-methoxyquinolone. Antimicrob Agts Chemother 41: 1818–1824
5. Barry AL, Jones RN (1989) In vitro activities of tmafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents. J Antimicrob Chemother 23: 527–35